unanswered questions regarding treatment cessation in cml
Published 2 years ago • 46 plays • Length 1:32Download video MP4
Download video MP3
Similar videos
-
1:11
gene therapy for scd: unanswered questions
-
0:57
unanswered questions in frontline cll treatment
-
2:18
treating patients with advanced-stage hl in the frontline and relapsed settings in 2024
-
1:01
advancements in cml: improving treatment-free remission and novel agents
-
6:35
measuring residual disease in granulocytes to predict relapse after therapy cessation in cml
-
2:12
key emerging trials in cml and the importance of improving treatment-free remission rates
-
0:58
reducing inequalities in the diagnosis and treatment of hematological malignancies
-
2:31
officials say 130 suspected victims of possible energy weapon
-
3:31
abbi evans - chronic myeloid leukaemia (cml) - spot leukaemia
-
9:51
børnecancerfonden 2013
-
2:06
an insight into the challenges and management of myeloproliferative neoplasm-unclassifiable (mpn-u)
-
1:25
therapeutic targeting of splicing factor mutations in myeloid malignancies
-
1:59
session overview: pitfalls in the diagnosis of bleeding disorders & research networks in the uk
-
1:05
the importance of using mrd to guide treatment decisions in all
-
1:18
the use of genomics to help select treatment in cll
-
1:03
an insight into the sequencing of immunotherapies in adults with all
-
1:17
novel agents to improve outcomes for patients with multiple myeloma in the salvage setting
-
1:26
improving outcomes in sickle cell disease: expanding access and expediting treatment development
-
1:42
optimal sequencing of immunotherapies to improve outcomes for patients with multiple myeloma
-
1:08
an insight into the mutational landscape and unique features of cmml
-
1:18
involving the patient in treatment decisions for cll